Founder & CEO
Chief Medical Officer
General Manager/Business Head Consumer Health
SVP of Quality, Regulatory, and Clinical Affairs
SVP of Manufacturing and Operations
SVP of Research & Development
VP of Finance
VP of People
Founder & CEO
Chairman of the Board
Forte Health Advisors
Exact Sciences
Ping An Global Voyager
Cedars-Sinai Medical Center
ND Captial
Artiman Ventures
Pitango Ventures
Kleiner Perkins
Lightrock
Healthcare of Ontario Pension Plan
Black Point Group
Chair of Scientific Advisory Board, University of Alabama at Birmingham
Brown University
University of Alabama at Birmingham
Stanford University
Co-founder & Former CTO
Nissim Capital, Former Board Member
Headquarters
3010 North First Street
San Jose, CA 95134
Dr. Schoolnik is Chief Medical Officer, Visby Medical. He is also Professor of Medicine (emeritus), Stanford Medical School, Attending Physician in Internal Medicine and Infectious Diseases at Stanford University Hospital and Associate Director of Stanford’s Institute for Immunology, Transplantation and Infection.
Dr. Schoolnik received his M.D. degree and infectious diseases subspecialty training at the University of Washington in Seattle, served as medical intern, resident and chief resident at Harvard’s Massachusetts General Hospital in Boston and he was a research associate and associate physician at the Rockefeller University in Manhattan. While on the Stanford Medical School faculty he served as Chief of the Division of Infectious Diseases and Geographic Medicine. National service included his appointment to the Advisory Council of the National Institutes of Allergy and Infectious Diseases of the NIH and his role as chair of the NIH Trans-Institute Committee on the Human Microbiome and co-chair of the NIH Blue Ribbon Committee on Bioterrorism. International consultative activities include the Board of Scientific Counselors of Fudan University in Shanghai.
He was founding editor of the journal Molecular Microbiology and Associate Editor of the Journal of Clinical Investigation. His academic research focuses on the molecular, genetic and genomic aspects of infectious agents and on the development of new drugs, vaccines and diagnostics. Gary has 6 issued patents.
Scott Verner was Chairman, CEO and President of TRIVIDIA Health, a leading developer and manufacturer of diabetes management solutions and blood glucose monitoring systems, formed in the merger of Nipro Diagnostics Inc. and assets of Sinocare, Inc. Before TRIVIDIA Health, Scott served as Chairman , President, and Group CEO of Nipro Diagnostics, Inc. and Chairman of two other affiliated businesses (Nipro Health Care and Applied Sciences Corporation).
Over the last 10 years, Scott has built shareholder value and created equity events for three public companies in the global consumer healthcare, medical device, and pharmaceutical industries. He possesses strong financial acumen, expertise in fund raising and restructuring debt, and operations experience with public companies, private equity, venture capital, and IPOs. Scott has an extensive record of achievement growing companies and brands, leading turnarounds, building world class sales and marketing capabilities, launching new products, and restructuring sales and marketing operations.